Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Annexin Pharmaceuticals

Market Cap: SEK 260.3m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

Scandion Oncology

Market Cap: SEK 4.4m

A clinical-stage biotechnology company, develops medicines for the treatment of cancer.

Initiator Pharma

Market Cap: SEK 202.2m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

SenzaGen

Market Cap: SEK 155.8m

Provides non-animal tests for assessing a substance’s allergenicity.

Devyser Diagnostics

Market Cap: SEK 1.8b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Enzymatica

Market Cap: SEK 735.5m

A life science company, develops and sells products that treat and alleviate infections and symptoms in the upper respiratory tract.

ODI Pharma

Market Cap: SEK 29.0m

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.

ExpreS2ion Biotech Holding

Market Cap: SEK 44.9m

Through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally.

BICO Group

Market Cap: SEK 2.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Mendus

Market Cap: SEK 250.5m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

Alzinova

Market Cap: SEK 187.6m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Genetic Analysis

Market Cap: NOK 59.3m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Moberg Pharma

Market Cap: SEK 411.4m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Hamlet BioPharma

Market Cap: SEK 684.1m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

Attana

Market Cap: SEK 40.0m

Provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

Nanologica

Market Cap: SEK 107.8m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Corline Biomedical

Market Cap: SEK 244.4m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Medivir

Market Cap: SEK 198.8m

A pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally.

LIDDS

Market Cap: SEK 5.6m

A drug delivery company, develops pharmaceutical products based on its NanoZolid proprietary technology for the treatment of cancer and other diseases in Sweden.

FluoGuide

Market Cap: SEK 592.5m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Kancera

Market Cap: SEK 123.4m

Develops drugs for inflammatory diseases and cancer in Sweden and internationally.

Pila Pharma

Market Cap: SEK 84.4m

Operates as a clinical stage biotech company in Sweden.

Spago Nanomedical

Market Cap: SEK 63.5m

A clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden.

Spermosens

Market Cap: SEK 10.3m

Provides diagnostic health care products and services in Sweden.

Stayble Therapeutics

Market Cap: SEK 25.4m

Develops injectable treatment for chronic pain triggered by disc degeneration.

NextCell Pharma

Market Cap: SEK 73.2m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

Vitrolife

Market Cap: SEK 21.3b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Prostatype Genomics

Market Cap: SEK 9.6m

Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests.

Egetis Therapeutics

Market Cap: SEK 1.2b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

Cantargia

Market Cap: SEK 387.3m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Cessatech

Market Cap: DKK 231.4m

A pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark.

Coegin Pharma

Market Cap: SEK 90.8m

A biotechnology company, engages in the discovery and development of dermacosmetic products and drugs for the treatment of serious diseases associated with diabetes and cancer.

Diamyd Medical

Market Cap: SEK 964.3m

Develops precision medicine therapies for the treatment of autoimmune diabetes.

OncoZenge

Market Cap: SEK 63.3m

A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.

Active Biotech

Market Cap: SEK 209.1m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

DanCann Pharma

Market Cap: DKK 6.6m

A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.